Prism Medico and Pharmacy Limited (PRISMMEDI.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-124.4%

-₹8.65

vs ₹35.50 price

Levered DCF

₹14.25

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

—

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	47.57×	-153.18×	-761.47×	-220.23×	-12.49×	-55.48×	-150.18×	60.49×
P/B	0.99×	0.49×	1.08×	1.14×	0.37×	0.55×	0.58×	1.7×
P/S	6.26×	11.8×	5.57×	13.66×	0.55×	0.42×	0.28×	0.62×
EV / EBITDA	37.11×	-96.64×	-117.58×	-177.98×	-9.32×	-42.94×	-148.01×	76.6×
Gross margin	33.2%	29.0%	12.5%	10.2%	-2.2%	0.6%	1.0%	3.0%
Operating margin	16.6%	-12.8%	-4.9%	-8.2%	-5.9%	-1.0%	-0.3%	0.2%
Net margin	13.0%	-7.7%	-0.7%	-6.0%	-4.4%	-0.8%	-0.2%	1.0%
Current ratio	77.37×	32.44×	147.68×	65.34×	708.22×	2.26×	2.29×	1.8×
Debt / equity	0×	0×	0×	0×	0×	0×	0×	0.17×
Interest coverage	123.24×	-47.47×	-20.17×	-345.33×	-997.29×	-709.78×	-272.12×	329.99×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	2.1%	-0.3%	-0.1%	-0.5%	-2.9%	-1.0%	-0.4%	2.8%
Return on invested capital	2.0%	-0.4%	-0.7%	-0.5%	-2.9%	-1.0%	-0.4%	0.5%
Return on assets	2.0%	-0.3%	-0.1%	-0.5%	-2.9%	-0.6%	-0.2%	2.2%
Free cash flow yield	0.0%	-0.2%	-0.0%	17.0%	-51.5%	-0.7%	-57.8%	-5.5%
Earnings yield	2.1%	-0.7%	-0.1%	-0.4%	-8.0%	-1.8%	-0.7%	1.7%
Enterprise value	₹152.2M	₹73.9M	₹162.1M	₹172.6M	₹45.7M	₹69.8M	₹74.4M	₹245.2M
Net debt / EBITDA	-0.16×	0.85×	0.61×	0.99×	0.11×	0.52×	2.22×	6.72×
Cash conversion cycle (days)	2,074	9,609	1,421	4,382	501	217	135	16